High blood pressure prevalence, awareness, treatment, and blood pressure control among Ugandans with rheumatic and musculoskeletal disorders.
Journal
PloS one
ISSN: 1932-6203
Titre abrégé: PLoS One
Pays: United States
ID NLM: 101285081
Informations de publication
Date de publication:
2023
2023
Historique:
received:
25
06
2022
accepted:
20
07
2023
medline:
9
8
2023
pubmed:
7
8
2023
entrez:
7
8
2023
Statut:
epublish
Résumé
Rheumatic and musculoskeletal disorders (RMDs) are associated with cardiovascular diseases (CVDs), with hypertension being the most common. We aimed to determine the prevalence of high blood pressure (HBP), awareness, treatment, and blood pressure control among patients with RMDs seen in a Rheumatology clinic in Uganda. We conducted a cross-sectional study at the Rheumatology Clinic of Mulago National Referral Hospital (MNRH), Kampala, Uganda. Socio-demographic, clinical characteristics and anthropometric data were collected. Multivariable logistic regression was performed using STATA 16 to determine factors associated with HBP in patients with RMDs. A total of 100 participants were enrolled. Of these, majority were female (84%, n = 84) with mean age of 52.1 (standard deviation: 13.8) years and median body mass index of 28 kg/m2 (interquartile range (IQR): 24.8 kg/m2-32.9 kg/m2). The prevalence of HBP was 61% (n = 61, 95% CI: 51.5-70.5), with the majority (77%, n = 47, 95% CI: 66.5-87.6) being aware they had HTN. The prevalence of HTN was 47% (n = 47, 37.2-56.8), and none had it under control. Factors independently associated with HBP were age 46-55years (adjusted prevalence ratio (aPR): 2.5, 95% confidence interval (CI): 1.06-5.95), 56-65 years (aPR: 2.6, 95% CI: 1.09-6.15), >65 years (aPR: 2.5, 95% CI: 1.02-6.00), obesity (aPR: 3.7, 95% CI: 1.79-7.52), overweight (aPR: 2.7, 95% CI: 1.29-5.77). There was a high burden of HBP among people with RMDs in Uganda with poor blood pressure control, associated with high BMI and increasing age. There is a need for further assessment of the RMD specific drivers of HBP and meticulous follow up of patients with RMDs.
Sections du résumé
BACKGROUND
Rheumatic and musculoskeletal disorders (RMDs) are associated with cardiovascular diseases (CVDs), with hypertension being the most common. We aimed to determine the prevalence of high blood pressure (HBP), awareness, treatment, and blood pressure control among patients with RMDs seen in a Rheumatology clinic in Uganda.
METHODS
We conducted a cross-sectional study at the Rheumatology Clinic of Mulago National Referral Hospital (MNRH), Kampala, Uganda. Socio-demographic, clinical characteristics and anthropometric data were collected. Multivariable logistic regression was performed using STATA 16 to determine factors associated with HBP in patients with RMDs.
RESULTS
A total of 100 participants were enrolled. Of these, majority were female (84%, n = 84) with mean age of 52.1 (standard deviation: 13.8) years and median body mass index of 28 kg/m2 (interquartile range (IQR): 24.8 kg/m2-32.9 kg/m2). The prevalence of HBP was 61% (n = 61, 95% CI: 51.5-70.5), with the majority (77%, n = 47, 95% CI: 66.5-87.6) being aware they had HTN. The prevalence of HTN was 47% (n = 47, 37.2-56.8), and none had it under control. Factors independently associated with HBP were age 46-55years (adjusted prevalence ratio (aPR): 2.5, 95% confidence interval (CI): 1.06-5.95), 56-65 years (aPR: 2.6, 95% CI: 1.09-6.15), >65 years (aPR: 2.5, 95% CI: 1.02-6.00), obesity (aPR: 3.7, 95% CI: 1.79-7.52), overweight (aPR: 2.7, 95% CI: 1.29-5.77).
CONCLUSION
There was a high burden of HBP among people with RMDs in Uganda with poor blood pressure control, associated with high BMI and increasing age. There is a need for further assessment of the RMD specific drivers of HBP and meticulous follow up of patients with RMDs.
Identifiants
pubmed: 37549138
doi: 10.1371/journal.pone.0289546
pii: PONE-D-22-18109
pmc: PMC10406225
doi:
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Research Support, U.S. Gov't, Non-P.H.S.
Langues
eng
Sous-ensembles de citation
IM
Pagination
e0289546Subventions
Organisme : FIC NIH HHS
ID : R25 TW011213
Pays : United States
Organisme : PEPFAR
Pays : United States
Informations de copyright
Copyright: © 2023 Kibone et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Déclaration de conflit d'intérêts
The authors have declared that no competing interests exist.
Références
Front Cardiovasc Med. 2022 Sep 15;9:939103
pubmed: 36187016
Circ Cardiovasc Qual Outcomes. 2022 Dec;15(12):e009046
pubmed: 36252134
Curr Hypertens Rep. 2018 Oct 5;20(12):100
pubmed: 30291560
Nat Rev Rheumatol. 2015 Dec;11(12):693-704
pubmed: 26282082
BMC Geriatr. 2021 Apr 19;21(1):260
pubmed: 33874889
J Clin Hypertens (Greenwich). 2008 Jan;10(1 Suppl 1):20-6
pubmed: 18174780
Medicina (Kaunas). 2019 Jun 06;55(6):
pubmed: 31174287
Rheumatology (Oxford). 2016 Jul;55(7):1210-6
pubmed: 27009825
Hypertension. 2020 May;75(5):1167-1178
pubmed: 32172619
Hypertension. 2022 Sep;79(9):1949-1961
pubmed: 35638381
Arthritis Rheumatol. 2015 Oct;67(10):2557-68
pubmed: 26352873
Ann Rheum Dis. 2017 Jan;76(1):9-16
pubmed: 27789466
BMC Med Res Methodol. 2003 Oct 20;3:21
pubmed: 14567763
Acad Emerg Med. 2002 Dec;9(12):1430-4
pubmed: 12460851
PLoS One. 2018 Aug 1;13(8):e0201001
pubmed: 30067823
Nat Rev Cardiol. 2018 Jan;15(1):33-44
pubmed: 28836617
PLOS Glob Public Health. 2022 May 10;2(5):e0000386
pubmed: 36962239
Mod Rheumatol. 2023 Jan 27;:
pubmed: 36715080
Arthritis Res Ther. 2013 Oct 02;15(5):R142
pubmed: 24286134
QJM. 2011 Jan;104(1):13-26
pubmed: 21068083
Arthritis Rheum. 1986 Aug;29(8):1039-49
pubmed: 3741515
J Hum Hypertens. 2021 May;35(5):419-427
pubmed: 32382031
Medicine (Baltimore). 2022 Jan 28;101(4):e28763
pubmed: 35089255
Am J Hypertens. 2021 Aug 9;34(7):683-685
pubmed: 33569585
Cell Mol Immunol. 2022 May;19(5):561-576
pubmed: 35354938
Rheumatol Ther. 2020 Mar;7(1):19-33
pubmed: 31853784
Ann Rheum Dis. 2011 Jan;70(1):25-31
pubmed: 21109520
Hypertension. 2020 Jun;75(6):1334-1357
pubmed: 32370572
Arthritis Rheum. 1991 May;34(5):505-14
pubmed: 2025304
CMAJ. 2020 Mar 23;192(12):E295-E301
pubmed: 32392512
Stat Med. 2016 Dec 30;35(30):5730-5735
pubmed: 27460748
Arthritis Rheumatol. 2019 Sep;71(9):1400-1412
pubmed: 31385462
J Hum Hypertens. 2022 May 3;:
pubmed: 35505225
J Hum Hypertens. 2023 Apr 19;:
pubmed: 37076570
Diabet Med. 2006 May;23(5):469-80
pubmed: 16681555
PLoS One. 2020 Jan 15;15(1):e0222801
pubmed: 31940346
Arthritis Rheum. 1990 Nov;33(11):1601-10
pubmed: 2242058
Arthritis Rheum. 2010 Sep;62(9):2569-81
pubmed: 20872595
PLoS Med. 2020 Jul 28;17(7):e1003198
pubmed: 32722671
Ageing Res Rev. 2016 Mar;26:96-111
pubmed: 26835847